Copyright
©The Author(s) 2025.
World J Orthop. Aug 18, 2025; 16(8): 107083
Published online Aug 18, 2025. doi: 10.5312/wjo.v16.i8.107083
Published online Aug 18, 2025. doi: 10.5312/wjo.v16.i8.107083
Table 3 Side effects during and after denosumab therapy, n (%)
Side effects | Frequency |
Hypercalcemia | 12 (29) |
Hypercalcemia + Growth plate ossification | 1 (2) |
Hypocalcemia + Hypercalcemia | 1 (2) |
Hypocalcemia + Hypophosphatemia + Hypercalcemia | 1 (2) |
Hypocalcemia + Hypophosphatemia | 1 (2) |
Vomiting | 1 (2) |
Not reported | 26 (60) |
Total | 43 |
- Citation: Machak GN, Bruland ØS, Kovalev AV, Rodionova SS. Rethinking the role of bisphosphonates after denosumab treatment in locally advanced or unresectable aneurysmal bone cysts: A meta-analysis. World J Orthop 2025; 16(8): 107083
- URL: https://www.wjgnet.com/2218-5836/full/v16/i8/107083.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i8.107083